$FVRR Balance Sheet | Understand Stock

$FVRR

$8.19 -$0.12 (1.44%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Marketable securities
User funds
Bank deposits
Short-term bank deposits
Restricted deposit
Prepaid expense and other receivables
Total current assets

Long-term assets:
Marketable securities
Property and equipment, net
Operating lease right-of-use assets
Deferred tax assets, net
Intangible assets, net
Goodwill
Restricted deposit
Other non-current assets
Total long-term assets

Total assets
Liabilities and shareholders’ equity
Current liabilities:
Trade payables
User accounts
Deferred revenue
Other account payables and accrued expenses
Operating lease liabilities
Current maturities of long-term loan
Convertible notes, net
Total current liabilities

Long-term liabilities:
Convertible notes, net
Operating lease liabilities
Long-term loan and other non-current liabilities
Other non-current liabilities
Total long-term liabilities

Total liabilities
Shareholders’ equity:
Ordinary shares of no par value – Authorized: 127,400,000 shares at December 31, 2025 and 2024; Issued and outstanding: 36,093,139 shares and 35,844,114 shares at December 31, 2025 and 2024, respectively.
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Total shareholders’ equity
Total liabilities and shareholders’ equity

Comments